Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Visscher

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2015
Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristicsKimberly A Bertrand, Christopher G Scott, Rulla M Tamimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Circulating sex hormones and terminal duct lobular unit involution of the normal breastZeina G Khodr, Mark E Sherman, Ruth M Pfeiffer, et al.
Gynecologic Oncology|March 17, 2015
Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometriumYvette P Geels, Louis J M van der Putten, Angela A G van Tilborg, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trialEdith A Perez, Monica M Reinholz, David W Hillman, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
NPJ Breast Cancer|January 20, 2022
Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learningThomas de Bel, Geert Litjens, Joshua Ogony, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2015
Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristicsKimberly A Bertrand, Christopher G Scott, Rulla M Tamimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.
Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Circulating sex hormones and terminal duct lobular unit involution of the normal breastZeina G Khodr, Mark E Sherman, Ruth M Pfeiffer, et al.
Gynecologic Oncology|March 17, 2015
Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometriumYvette P Geels, Louis J M van der Putten, Angela A G van Tilborg, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trialEdith A Perez, Monica M Reinholz, David W Hillman, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
NPJ Breast Cancer|January 20, 2022
Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learningThomas de Bel, Geert Litjens, Joshua Ogony, et al.
Pageof 13